EN1 (engrailed homeobox 1) is a homeodomain transcription factor that functions as both a developmental regulator and aberrant oncogenic driver. During normal development, EN1 is essential for proper limb formation, specifically required for apical ectodermal ridge development and dorsal-ventral patterning [UniProt annotation]. EN1 acts as a sequence-specific DNA-binding transcription factor that regulates transcription through RNA polymerase II mechanisms and is critical for dopaminergic neuron differentiation and skeletal system development [GO annotations]. In the context of stem cell biology, EN1 serves as a key marker of authentic midbrain dopamine (mDA) neurons derived from human pluripotent stem cells; optimized differentiation protocols enhance EN1 expression to improve mDA neuron yield and quality for Parkinson's disease applications 12. EN1 also influences Hedgehog signaling by regulating Gli1 expression and primary cilia properties 3. Pathologically, EN1 is aberrantly expressed across multiple cancer types. In triple-negative breast cancer, EN1 cooperates with BRD4-S to comodulate extracellular matrix genes and cancer-associated pathways 4. EN1 functions as an oncogenic driver in pancreatic cancer, promoting metastasis through MAPK pathway activation and mesenchymal transition 5, and in glioblastoma, where elevated expression predicts poor prognosis and promotes proliferation via Hedgehog signaling 3. Additionally, non-coding variants near EN1 significantly influence bone mineral density and fracture risk 6.